Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Mighty bold lies told about MYDX product releases, which never happened, contributed to the company SP going from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
With Vegas tourist dollars not coming in, It actually is good news PLNHF did not get Santa Ana -- $6M alone to get the license, then the tens of millions for buildout costs. And the buildout probably would not have begun for many months to come, but the company would have been on the hook for expenses.
This stock has been no-bid for several months now.
This stock belongs to a company that has been saying since 2015 products are “coming soon.”
This stock is of a company that pays its CEO $10K a month and there has been zero news or updates for over four months now.
This stock belongs to a company that is being sued by the company’s former Chief Medical Officer and accuses MYDX’s CEO of misrepresentation and spending her company’s money on things outside the company.
This stock belongs to a company that has one product out, and that one product is over five years old.
I sold my GRWG position, ending up with ~75% profit.
Why did the selling stop? Look at the SP when the selling stopped and then cross-reference financials and Form 4s to see insiders aren’t going to sell now (even though Lampert got 200,000 more shares at $0.00 on Jan 1st). The cross-referencing won’t get all the answers, but it’ll show that selling at the current SP wouldn’t be a good idea.
I don’t discount the possibility Gotham Green ate their Wheaties and simply sold at the right time, who knows. I will say they started selling when COVID-19 gripped China, so they could have simply timed things out well. Or they could have gotten information second or third-hand that is putting some US Senators in hot water right now. Can’t say for sure either way.
As for the price paid, that’s basic fundamentals. How much debt is this company taking on? The company regularly boasts about how much revenue the acquisition did, I simply want to know how much they paid for it. I don’t buy the argument about keeping things secret, acquisitions are a material event and should be fully disclosed. It’s not a all about the numbers, but also about being forthcoming and transparency. ESPECIALLY in the shady cannabis sector.
And think about this for moment....if these guys make such “great deals,” wouldn’t you want to brag about that? That’s music to the ears of investors. That would change my mind about things.
In their last 10-K, GRWG sales doubled but so did their loss compared to the previous year. If that path continues, the SP will continue to languish. I get the feeling that’s what the company is trying to avoid revealing.
If you’re up 100% on a trade how much do you sell to take profit? Greed is not the way to make money in the market as we are witnessing these days. Weird how the faucet turned off when we dipped?
Let’s just say you’re right? Why only a controlled portion around and above 5? Why did it stop?
As to your concern about price paid. This is a highly sought after space. Why would you want your company to publicly share the deals they make?
I’ve heard from several people in the know (albeit I don’t have verifiable proof) that these guys make great deals. That was Why I even knew about them in the first place.
Relax. Smoke something. If you are holding this well be back at 6 in no time. Best of luck.
I sold my entire GRWG for a nice profit, been waiting for the right time to get back in. That right time has been more elusive given the insider sell-off over the past few months and lack of transparency by the company on how much the company has paid for recent acquisitions.
Insiders and investors sell, to be expected. It's the amount of selling lately that has held back GRWG and made those target prices become even more elusive than they already were. Twenty-five Form 4s in eight weeks is NOT normal.
And I'll say again that if these additional revenue streams are so beneficial to the company, it's time Lampert consider more compensation by traditional means, and not dilution. The company can hide behind behind Emerging Growth for only so long.
On March 30th we still probably won't know exactly how much was paid for each acquisition, but we'll find out how much is owed in general.
Yes the market overall plays a role, but then again the "creative accounting and stock buybacks" didn't stop a purchase of GRWG at $4.28, even after acknowledging the market was crashing.
Mighty bold lies told about MYDX product releases, that never happened, contributed to the company SP going from $3.00 to $0.000001. Including the alleged imminent debut on a e-commerce site on October 17, 2018 at 12:01 a.m. (which never happened), plus Slimpen imminent release on four different occasions damaged MYDX.
Not fear, only suspicion at this point. The entire sector has earned a reputation of questionable companies and tactics and is littered with the carcasses of “solid” CEOs.
I’m NOT saying GRWG is knavish, yet the company doesn’t seem as transparent today as it was when I first bought shares of it.
News 
Market Data 
Discover 
AI
